Clinical Study

Cognitive Stimulation for Individuals with Parkinson’s Disease Dementia Living in Long-Term Care: Preliminary Data from a Randomized Crossover Pilot Study

Table 2

Medians and ranges of all main outcomes for all time points of measurement differentiated for intervention and control group and related within- and between-comparisons.

Cognitive stimulation ()Usual care ()Cognitive stimulation vs. usual care
PreinterventionPostinterventionWithin-comparisonsFollow-upWithin-comparisonsPre-usual carePost-usual careWithin-comparisonsBetween-comparisons
Median (range)Median (range)rMedian (range)rMedian (range)Median (range)rr

Cognition
CERAD total scorea35.50 (20–61)43.50 (23–73)0.0600.7049.50 (15.00–69.00)20.1610.4040.50 (19–58)28.50 (20–57)0.3450.270.0670.43

Depression
GDSb8.50 (3–14)6.00 (3–12)50.9500.213.00 (1–11)30.0720.618.50 (4–14)10.50 (3–14)0.8320.330.8080.22
CSDDb3.00 (0–18)2.00 (0–15)1.0000.041.00 (0–14)40.3200.415.00 (4–8)4.00 (2–13)1.0000.040.5000.28

Neuropsychiatric symptoms
NPI total score (items A–L)b10.00 (1–35)58.00 (0–51)50.4390.227.50 (0–41)40.5750.1610.00 (1–21)113.00 (5–35)0.4140.330.0750.42
Activities of daily living (ADL)
Barthel Indexa14.50 (2–20)15.00 (4–20)50.5720.1613.50 (0–18)40.0140.7115.50 (9–20)15.50 (9–20)0.4140.330.9610.02

Quality of Life
EQ-5D-5L index valuea0.68 (0.09–1.00)0.71 (0.09–1.00)51.0000.060.74 (0.05–0.83)41.0000.340.71 (0.11–0.99)0.71 (0.16–1.00)0.5450.651.0000.08
EQ-5D-5L-VASa55.00 (5–85)65.00 (45–80)50.7000.4355.00 (35–90)31.0000.2850.00 (40–80)55.00 (5–75)1.0000.041.0000.24
EQ-5D-5L index value (proxy)a0.73 (0.02–1.00)0.73 (0.14–0.93)1.0000.150.76 (0.09–1.00)31.0000.200.72 (0.51–0.91)0.73 (0.54–1.00)1.0000.171.0000.12
EQ-5D-5L-VAS (proxy)a57.50 (10–90)50.00 (25–80)1.0000.1960.00 (40–80)31.0000.2750.00 (35–60)52.50 (10–70)1.0000.171.0000.06
QUALIDEM total scorea16.77 (8.53–22.25)417.24 (13.36–24.83)50.4300.5017.43 (7.70–23.50)30.4550.4917.96 (13.79–22.52)116.32 (13.45–17.78)11.0000.300.9950.33

Statistical trends are in italics. Abbreviations: CERAD, Consortium to Establish a Registry for Alzheimer's Disease; GDS, Geriatric Depression Scale; CSDD, Cornell Scale for Depression in Dementia; NPI, Neuropsychiatric Inventory; VAS, visual analog scale. aHigher scores indicate a better performance. bLower scores indicate a better performance. 1; 2; 3; 4; 5.